Cargando…
Altered metabolic landscape in IDH‐mutant gliomas affects phospholipid, energy, and oxidative stress pathways
Heterozygous mutations in NADP‐dependent isocitrate dehydrogenases (IDH) define the large majority of diffuse gliomas and are associated with hypermethylation of DNA and chromatin. The metabolic dysregulations imposed by these mutations, whether dependent or not on the oncometabolite D‐2‐hydroxyglut...
Autores principales: | Fack, Fred, Tardito, Saverio, Hochart, Guillaume, Oudin, Anais, Zheng, Liang, Fritah, Sabrina, Golebiewska, Anna, Nazarov, Petr V, Bernard, Amandine, Hau, Ann‐Christin, Keunen, Olivier, Leenders, William, Lund‐Johansen, Morten, Stauber, Jonathan, Gottlieb, Eyal, Bjerkvig, Rolf, Niclou, Simone P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709746/ https://www.ncbi.nlm.nih.gov/pubmed/29054837 http://dx.doi.org/10.15252/emmm.201707729 |
Ejemplares similares
-
FSMP-07. CYSTATHIONINE-Γ-LYASE DRIVES ANTIOXIDANT DEFENSE IN CYSTEINE-RESTRICTED IDH1 MUTANT ASTROCYTOMAS
por: Cano-Galiano, Andrés, et al.
Publicado: (2021) -
Cystathionine-γ-lyase drives antioxidant defense in cysteine-restricted IDH1-mutant astrocytomas
por: Cano-Galiano, Andrés, et al.
Publicado: (2021) -
The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status
por: Johansson, Mikael, et al.
Publicado: (2013) -
Glutamine Synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma
por: Tardito, Saverio, et al.
Publicado: (2015) -
Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy
por: Klein, Eliane, et al.
Publicado: (2020)